España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Elevation Oncology
ELEV
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.6932
0.03
3.99%
At close: -
$0.7000
0.00680
0.98%
After Hours: Jan 31, 7:05 PM EDT
Get Report
Comment
Elevation Oncology (ELEV) Forecast
News
Earnings
Elevation Oncology (ELEV) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Elevation Oncology (NASDAQ:ELEV) Stock
Elevation Oncology Stock (NASDAQ: ELEV)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, January 14, 2025
HC Wainwright & Co. Reiterates Buy on Elevati...
Benzinga Newsdesk
Monday, January 13, 2025
Elevation Oncology shares are trading higher ...
Benzinga Newsdesk
Elevation Oncology Advances EO-3021 Trials to...
Benzinga Newsdesk
Friday, January 03, 2025
Elevation Oncology: Promising Cancer Therapies Earn Analyst Praise
Vandana Singh
This Denali Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Friday
Avi Kapoor
William Blair Initiates Coverage On Elevation...
Benzinga Newsdesk
Thursday, December 19, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Friday, December 13, 2024
HC Wainwright & Co. Reiterates Buy on Elevati...
Benzinga Newsdesk
Thursday, December 12, 2024
Elevation Oncology Reports Nomination Of EO-1...
Benzinga Newsdesk
Friday, December 06, 2024
Stephens & Co. Reiterates Overweight on Eleva...
Benzinga Newsdesk
Thursday, December 05, 2024
Elevation Oncology Announced New Preclinical ...
Benzinga Newsdesk
Wednesday, October 09, 2024
Biden-Harris Administration Proposes Medicare...
Benzinga Newsdesk
Friday, September 27, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Monday, September 23, 2024
Elevation Oncology's EO-3021 Granted FDA Fast...
Benzinga Newsdesk
Wednesday, August 07, 2024
HC Wainwright & Co. Reiterates Buy on Elevati...
Benzinga Newsdesk
Tuesday, August 06, 2024
S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates
Avi Kapoor
Why Is Penny Stock Elevation Oncology Trading Lower On Tuesday?
Vandana Singh
Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings
Avi Kapoor
Dow Jumps Over 300 Points; US Trade Gap Narrows In June
Avi Kapoor
Elevation Oncology shares are trading lower. ...
Benzinga Newsdesk
Elevation Oncology Expects Its Existing Cash,...
Benzinga Newsdesk
Elevation Oncology Q2 2024 GAAP EPS $(0.18) B...
Benzinga Newsdesk
Elevation Oncology Reports Initial Data From ...
Benzinga Newsdesk
Friday, August 02, 2024
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing (CORRECTED)
Michael Juliano
Monday, July 15, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Friday, June 28, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Thursday, June 27, 2024
Elevation Oncology Plans To Expand Its Ongoin...
Benzinga Newsdesk
Friday, May 31, 2024
Piper Sandler Initiates Coverage On Elevation...
Benzinga Newsdesk
Tuesday, May 14, 2024
Stephens & Co. Initiates Coverage On Elevatio...
Benzinga Newsdesk
Monday, May 13, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, May 03, 2024
Wedbush Reiterates Outperform on Elevation On...
Benzinga Newsdesk
Thursday, May 02, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Elevation Oncology shares are trading lower a...
Benzinga Newsdesk
Elevation Oncology Says Cash, Cash Equivalent...
Benzinga Newsdesk
Elevation Oncology Q1 2024 GAAP EPS $(0.23) M...
Benzinga Newsdesk
Tuesday, April 09, 2024
HC Wainwright & Co. Reiterates Buy on Elevati...
Benzinga Newsdesk
Monday, April 08, 2024
Elevation Oncology Presents Preclinical Proof...
Benzinga Newsdesk
Wednesday, April 03, 2024
Watching Elevation Oncology; Traders Circulat...
Benzinga Newsdesk
Tuesday, March 26, 2024
HHS Says In 2025, All People With Medicare Pa...
Benzinga Newsdesk
Thursday, March 07, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Wedbush Maintains Outperform on Elevation Onc...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Elevati...
Benzinga Newsdesk
Wednesday, March 06, 2024
Recap: Elevation Oncology Q4 Earnings
Benzinga Insights
Elevation Oncology Q4 EPS $(0.19) Beats $(0.2...
Benzinga Newsdesk
Tuesday, March 05, 2024
Elevation Oncology To Present Preclinical Pro...
Benzinga Newsdesk
Friday, March 01, 2024
JMP Securities Initiates Coverage On Elevatio...
Benzinga Newsdesk
Thursday, February 22, 2024
Elevation Oncology Announced That It Has Expa...
Benzinga Newsdesk
Tuesday, February 20, 2024
HC Wainwright & Co. Maintains Buy on Elevatio...
Benzinga Newsdesk
Wednesday, January 31, 2024
How Is The Market Feeling About Elevation Oncology?
Benzinga Insights
Show More